VanishPoint -Model U-100 -Insulin Syringe
Prepare and give injection using aseptic technique according to institutional policy. For injection into patients, continue depressing plunger to activate automatic needle retraction while needle is still inpatient Full dose is administered only when needle retraction is activated
Most popular related searches
human immunodeficiency virus HIV
human immunodeficiency virus
sharps container
hepatitis virus
hepatitis C
hepatitis B
insulin syringe
depression
hiv virus
disposable needle
Product Usage Information:
- Needle will automatically retract into syringe, preventing exposure to contaminated needle and rendering syringe non-reusable. In the event that needle retraction mechanism does not activate, discard syringe in an appropriate sharps container per protocol of institution. Do not recap contaminated needles.
- Dispose of VanishPoint® syringe in an appropriate sharps container per protocol of institution.
Precautions:
- Use U-100 Insulin only.
- Single use only. Reuse of this device may result in exposure to bloodborne pathogens, including Hepatitis B virus (HBV), Hepatitis C virus (HCV), and human immunodeficiency virus (HIV).
- Contents are sterile, non-toxic, and non-pyrogenic. Do not use if product or package is damaged.
- Not made with natural rubber latex.
- Use only with attached needle. Needle cannot be changed.
- Automated needle retraction occurs only when barrel is emptied and plunger is fully depressed.
- U.S. Federal Law restricts this device to sale by or on the order of a physician.